Abstract
Oestrogens are prescribed to women in two circumstances — as part of oral contraceptive preparations, or as postmenopausal hormone replacement therapy. Oestrogens may also be prescribed to men as part of the treatment of prostatic carcinoma or to lower plasma cholesterol. The relationship of oestrogens and, in the case of oral contraceptives, progestogens to cardiovascular disease has been studied in all these circumstances. This chapter will review the evidence of a relationship between these sex hormones and disease of the coronary or cerebral arteries. Oestrogens are also associated with venous thromboembolism but this will not be discussed here.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stadel, B. V. (1981). Oral contraceptives and cardiovascular disease. N. Engl. J. Med., 305, 612 and 672
Vessey, M. P. (1980). Female hormones and vascular disease — an epidemiological overview. Br. J. Fam. Plan., 6, 1
Radford, D. J. and Oliver, M. F. (1973). Oral contraceptives and myocardial infarction. Br. Med. J., 3, 428
Mann, J. I., Vessey, M. P., Thorogood, M. and Doll, R. (1975). Myocardial infarction in young women with special reference to oral contraceptive practice. Br. Med J., 2, 241
Mann, J. I., Thorogood, M., Waters, W. E. and Powell, C. (1975). Oral contraceptives and myocardial infarction in young women: a further report. Br. Med. J., 3, 631
Mann, J. I. and Inman, W. H. W. (1975). Oral contraceptives and death from myocardial infarction. Br. Med. J., 2, 245
Mann, J. I., Inman, W. H. W. and Thorogood, M. (1976). Oral contraceptive use in older women and fatal myocardial infarction. Br. Med. J., 2, 445
Shapiro, S., Shone, D., Rosenberg, L., Kaufman, D. W., Stolley, P. D. and Miettinen, O. S. (1979). Oral contraceptive use in relation to myocardial infarction. Lancet, 1, 743
Jick, H., Dinan, B. and Rothman, K. J. (1978). Oral contraceptives and nonfatal myocardial infarction. J. Am. Med. Assoc., 239, 1403
Petitti, D. B., Wingerd, J., Pellegrin, F. and Ramcharan, S. (1979). Risk of vascular disease in women. J. Am. Med. Assoc., 242, 1150
Royal College of General Practitioners’ Oral Contraception Study (1981). Further analyses of mortality in oral contraceptive users. Lancet, 1, 541
Krueger, D. E., Ellenberg, S. S., Bloom, S. et al. (1980). Fatal myocardial infarction and the role of oral contraceptives. Am. J. Epidemiol, 111, 655
Royal College of General Practitioners (1977). Mortality among oral contraceptive users. Lancet, 2, 727
Vessey, M., Doll, R., Peto, R., Johnson, B. and Wiggins, P. (1976). A long term follow- up study of women using different methods of contraception — an interim report. J. Biosoc. Sci., 8, 373
Vessey, M. P., McPherson, K. and Johnson, B. (1977). Mortality among women participating in the Oxford/Family Planning Association contraceptive study. Lancet, 2, 731
Vessey, M. P., McPherson, K. and Yeates, D. (1981). Mortality in oral contraceptive users. Lancet, 1, 549
Slone, D., Shapiro, S., Kaufman, D. W., Rosenberg, L., Miettinen, O. S. and Stolley, P. D. (1981). Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives. N. Engl. J. Med., 305, 420
Meade, T. W., Greenberg, G. and Thompson, S. G. (1980). Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-μg oestrogen preparations. Br. Med. J., 280, 1157
Collaborative Group for the study of stroke in young women (1973). Oral contraceptives and increased risk of cerebral ischaemia or thrombosis. N. Engl. J. Med., 288, 871
Irey, N. N. and Norris, H. J. (1973). Intimal vascular lesions associated with female reproductive steroids. Arch. Pathol., 96, 227
Irey, N. N., Manion, W. C. and Taylor, H. B. (1970). Vascular lesions in women taking oral contraceptives. Arch. Pathol., 89, 1
Gammel, E. B. (1976). Intimal thickening in arteries of rats treated with synthetic sex hormones. Br. J. Exp. Pathol., 57, 248
Spain, D. M. (1978). Concerning the pathology of acute coronary heart disease in young women. In Oliver, M. F. (ed.) Coronary Heart Disease in Young Wome., pp. 61–70. (Edinburgh: Churchill Livingstone)
Weir, R. J., Briggs, E., Mack, A., Naiswith, L., Taylor, L. and Wilson, E. (1974). Blood pressure in women taking oral contraceptives. Br. Med. J., 1, 533
Stern, M. P., Brown, B. W., Haskell, W. L., Farquhar, J. W., Wehrle, C. L. and Wood, P. D. S. (1976). Cardiovascular risk and use of estrogens or estrogen-progestagen combinations. J. Am. Med. Assoc., 235, 811
Ostrander, L. D. Jr, Lamphiear, D. E., Block, W. D., Williams, G. W. and Carmen, W. J. (1980). Oral contraceptives and physiological variables. J. Am. Med. Assoc., 244, 677
Bengtsson, C. (1977). Arterial hypertension as a risk factor for ischemic heart disease in women — results from a retrospective and from a prospective study. Acta Med. Scand., suppl. 602, 44
Kannel, W. B., Schwartz, M. J. and McNamara, P. M. (1969). Blood pressure and risk of coronary disease. The Framingham study. Dis. Chest, 56, 43
Kannel, W. B., Wolf, P. A., Verter, J. and McNamara, P. M. (1970). Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study. J. Am. Med. Assoc., 214, 301
Engel, H. J., Hundeshagen, H. and Lichtlen, P. (1977). Transmural myocardial infarction in young women taking oral contraceptives. Evidence of reduced regional coronary flow in spite of normal coronary arteries. Br. Heart J., 39, 477
Bolton, G. H., Hampton, J. R. and Mitchell, J. R. A. (1968). Effect of oral contraceptive agents on platelets and plasma phospholipids. Lancet, 1, 1336
Poller, L., Priest, C. M. and Thompson, J. M. (1969). Platelet aggregation during oral contraception. Br. Med. J., 4, 273
Elkeles, R. S., Hampton, J. R. and Mitchell, J. R. A. (1968). Effects of oestrogen on human platelet behaviour. Lancet, 2, 315
Poller, L. (1976). Oral contraception and blood clotting. In Gillingham, F. J., Maudsley, C. and Williams, A. E. (eds.) Strok., pp. 315–46. (Edinburgh: Churchill Livingstone)
Meade, T. W., Chakrabarti, R., Haines, A. P., Howarth, D. J., North, W. R. S. and Stirling, Y. (1977). Haemostatic, lipid and blood-pressure profiles of women on oral contraceptives containing 50 mg or 30 mg oestrogen. Lancet, 2, 948
Carvalho, A. C. A., Vaillancourt, R. A., Cabral, R. B., Lees, R. S. and Colman, R. W. (1977). Coagulation abnormalities in women taking oral contraceptives. J. Am. Med. Assoc., 237, 875
Wessler, S. (1980). Thrombosis and sex hormones: a perplexing liaison. J. Lab. Clin. Med., 96, 759
Rosenberg, L., Armstrong, B. and Jick, H. (1976). Myocardial infarction and estrogen therapy in postmenopausal women. N. Engl. J. Med., 294, 1256
Pfeffer, R. I. and Van der Neort, S. (1976). Estrogen use and stroke risk in postmenopausal women. Am. J. Epidemiol., 103, 445
Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T. and Chapman, J. M. (1978). Coronary risk and estrogen use in postmenopausal women. Am. J. Epidemiol., 107, 479
Rosenberg, L., Slone, D., Shapiro, S., Kaufman, D., Stolley, P. D. and Miettinen, O. S. (1979). Noncontraceptive estrogens and myocardial infarction in young women. J. Am. Med. Assoc., 244, 339
Bain, C., Willett, W., Hennekens, C. H., Rosner, B., Belanger, C. and Speizer, F. E. (1980). Use of postmenopausal hormones and risk of myocardial infarction Circulation, 64, 42
Adam, S., Williams, V. and Vessey, M. P. (1981). Cardiovascular disease and hormone replacement treatment: a pilot case control study. Br. Med. J., 282, 1277
Gordon, T., Kannel, W. B., Hjortland, M. C. and McNamara, P. M. (1978). Menopause and coronary heart disease. The Framingham study. Ann. Intern. Med., 89, 157
Jick, H., Dinan, B. and Rothman, K. J. (1978). Noncontraceptive estrogens and nonfatal myocardial infarction. J. Am. Med. Assoc., 239, 1407
Jick, H., Dinan, B. and Rothman, K. J. (1978). Myocardial infarction and other vascular diseases in young women. J. Am. Med. Assoc., 240, 2548
Ross, R. K., Paganni-Hill, A., Mack, T. M., Arthur, M. and Henderson, B. E. (1981). Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet, 1, 858
Wallace, R. B., Hoover, J., Sandler, D., Rifkind, B. M. and Tyroler, H. A. (1977). Altered plasma-lipids associated with oral contraceptive or oestrogen consumption. Lancet, 2, 11
Barrett-Connor, E., Brown, V., Turner, J., Austin, M. and Criqui, M. H. (1979). Heart disease risk factors and hormone use in postmenopausal women. J. Am. Med. Assoc., 24, 2167
Hammond, C. B., Jelovsek, F. R., Lee, K. L., Creasman, W. T. and Parker, R. T. (1979). Effects of long-term estrogen replacement therapy. Am. J. Obstet. Gynecol., 133, 525
Lindquist, O. and Bengtsson, C. (1980). Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Goteborg, Sweden. Scand. J. Clin. Invest., 40, 629
Oliver, M. F. and Boyd, G. S. (1961). Influence of reduction of urn lipids on prognosis of coronary heart-disease. Lancet, 2, 499
Stamler, J., Pick, R., Katz, L. N. et al. (1965). Effectiveness of estrogen for therapy of myocardial infarction in middle aged men. J. Am. Med. Assoc., 183, 632
Marmorstom, J., Moore, F. J., Hopkins, C. E., Kuzma, O. T. and Weiner, J. (1962). Clinical studies of long-term estrogen therapy in men with myocardial infarction. Proc. Soc. Exp. Biol., 110, 400
McDowell, F., Louis, S. and McDevitt, E. (1967). A clinical trial of premarin in cerebrovascular disease. J. Chron. Dis., 20, 679
Veterans Administration Co-operative Urological Research Group (1967). Treatment and survival of patients with cancer of the prostate. Surg. Gynecol. Obstet., 124, 1011
Coronary Drug Project Research Group (1970). The Coronary Drug Project. Initial findings leading to modifications of its research protocol. J. Am. Med. Assoc., 214, 1303
Coronary Drug Project Research Group (1973). The Coronary Drug Project. Findings leading to discontinuation of the 2.5 mg/day estrogen group. J. Am. Med. Assoc., 226, 652
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1982 R. W. Stout
About this chapter
Cite this chapter
Stout, R.W. (1982). Oestrogens, progestogens and cardiovascular disease. In: Hormones and Atherosclerosis. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6264-7_10
Download citation
DOI: https://doi.org/10.1007/978-94-011-6264-7_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6266-1
Online ISBN: 978-94-011-6264-7
eBook Packages: Springer Book Archive